Form 8-K - Current report:
SEC Accession No. 0000950170-23-026749
Filing Date
2023-06-07
Accepted
2023-06-07 09:00:46
Documents
14
Period of Report
2023-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20230607.htm   iXBRL 8-K 59173
2 EX-99.1 drrx-ex99_1.htm EX-99.1 27153
3 GRAPHIC img178542993_0.jpg GRAPHIC 3939
  Complete submission text file 0000950170-23-026749.txt   218315

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drrx-20230607_pre.xml EX-101.PRE 10669
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drrx-20230607_lab.xml EX-101.LAB 17029
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drrx-20230607.xsd EX-101.SCH 2468
8 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20230607_htm.xml XML 4508
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 23997789
SIC: 2834 Pharmaceutical Preparations